Why Investors Need to Watch Cambrex Corporation
Here's why Cambrex stock is lighting up on the watchlist today.
Why Wall Street Is Excited about Alexion Pharmaceuticals
The fourth-quarter update from Alexion Pharmaceuticals, Inc. led to upgrades from Wall Street. Here's why.
These Momentum Stocks Are On a Roll
You don't have to wait for momentum stocks to move -- they've already been moving.
Today’s 3 Worst Stocks in the S&P 500
From Chesapeake Energy to Gilead Sciences, today's underperformers failed to impress investors
Reflections on the Biotech Earnings Bonanza: LLY, NVO, GILD
A look at some of top names in biotech show that the sector is still growing and 2014 could be another banner year.